Asthma (in children) - corticosteroids (TA131)
Fast, easy summary view of NICE guidance on 'asthma'
If inhaled corticosteroids are appropriate for children aged under 12 years who have chronic asthma, the least expensive product that is suitable for the individual child should be used.
If both an inhaled corticosteroid and a long-acting beta-2 agonist are needed, then a combination device that contains both medicines may be used. The decision to use a combination device should be based on the individual child and their asthma. If a combination device is chosen, the least expensive device that is suitable for the individual child should be used.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: asthma
This page was last updated: 02 April 2014
- Web format
- Quick reference guide (PDF)
- Full Guidance (PDF)
- TA131 Corticosteroidau a anadlir ar gyfer trin asthma cronig mewn plant o dan 12 oed: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.